PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 16 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Isolated bufadienolides from Melianthus major leaves exhibited strong cytotoxicity against MCF-7 breast cancer cells and sensitive CCRF-CEM and multidrug-resistant CEM/ADR5000 leukemia cells, with compound 1 showing the most potent activity [PMID:32663024].
Ethanol extracts of Melianthus comosus significantly inhibited the secretion of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α in LPS-stimulated macrophages [PMID:38310564].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37482193 (2023) — Honey flower dermatitis: Contact allergy to ellagic acid in Melianthuscomosus. · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
- 2.PMID: 32663024 (2020) — Cytotoxic Bufadienolides from the Leaves of Melianthus major. · Journal of natural products
- 3.PMID: 38310564 (2024) — Leaf extracts of eight selected southern African medicinal plants modulate pro-inflammatory cytokine secretion in LPS-stimulated RAW 264.7 macrophages. · Inflammopharmacology